FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma

Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: FID007 Sponsors: Fulgent Pharma LLC. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials